The Size of the Middle East & Africa Proteins Assays Market is valued at USD 0.13 Billion in 2019 and estimated to be growing at a CAGR of 11.31%, to reach USD 0.22 Billion by 2024 during the forecast period 2019-2024.
Protein quantification is an important step of the daily workflow of protein extraction in biochemistry and molecular biology that involves protein extraction, analysis or labeling. Quantification of proteins is essential for any sample before isolation, during separation and analysis by electrophoresis or chromatography or any other techniques. There are numerous methods to estimate the concentration of protein like Bradford, Lowry, BCA and UV spectroscopic Protein assays.
Market Drivers:
Increasing incidence rate of chronic diseases like cardiovascular, neurological and other infectious diseases, rapid technological advancements in protein assay techniques, increasing expenditure on pharmaceutical and biological R&D, increase in government funding and initiatives are the factors driving the growth of the market. Nonetheless, unapproved bipolar drugs, adverse drug reactions of anticonvulsants and stringent regulatory framework and may obstruct the growth of the market. Rising application of protein content determination in various fields related to pharmacy and biotechnology has stimulated the growth of the market.
This research report on the Middle East & Africa Proteins Assays Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.
By Product: Reagents, Kits, Instruments.
By Type: Dye-Binding, Copper-Ion Based, Test Strip
By Technology: Absorbance, Colorimetric, Fluorescence
By Application: Drug Discovery, Diagnosis
By End User: Academic And Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals, Clinical Laboratories
By Country: KSA, UAE, Israel, the rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA.
Middle East is leading the market while Africa is in second place. Growth in Pharmaceutical and biotechnological industries, a strong trend of R&D in the life sciences industry, increasing private-public partnership for drug development has helped these regions dominate the market. The Middle East is also expected to grow the fastest due to increasing research funding, growing proteomics and genomics techniques and rising adoption of advanced Proteins Assays techniques. Dye binding proteins assays segment holds the major share in the market based on type, due to increasing usage of dye-binding assays in disease diagnosis. Absorbance-based protein assays held a major share in the market based on technology due to increased sensitivity and accuracy of this technology.
Noteworthy Companies leading this Middle East & Africa Proteins Assays Market Profiled in the Report are Abcam PLC., Bio-Rad Laboratories Inc., Biovision Inc., Cell Signaling Technology Inc, GE Healthcare, PerkinElmer Inc., Thermo Fisher Scientific, Geno Technology Inc., Lonza Group, Merck KGaA, Novus Biologicals, LLC.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Reagents
5.1.3 Kits
5.1.4 Instruments and Services
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Dye-Binding Assays
5.2.3 Copper-Ion-Based Assays
5.2.4 Test Strip-Based Assays
5.2.5 Other Protein Assays
5.2.6 Y-o-Y Growth Analysis, By Type
5.2.7 Market Attractiveness Analysis, By Type
5.2.8 Market Share Analysis, By Type
5.3 Technology
5.3.1 Introduction
5.3.2 Absorbance-Based Protein Assays
5.3.3 Colorimetric Protein Assays
5.3.4 Fluorescence-Based Protein Assays
5.3.5 Y-o-Y Growth Analysis, By Technology
5.3.6 Market Attractiveness Analysis, By Technology
5.3.7 Market Share Analysis, By Technology
5.4 Application
5.4.1 Introduction
5.4.2 Drug Discovery & Development
5.4.3 Disease Diagnosis
5.4.4 Other Applications
5.4.5 Y-o-Y Growth Analysis, By Application
5.4.6 Market Attractiveness Analysis, By Application
5.4.7 Market Share Analysis, By Application
5.5 End User
5.5.1 Introduction
5.5.2 Academic and Research Institutes
5.5.4 Pharmaceutical & Biotechnology Companies
5.5.4 Hospitals
5.5.5 Clinical Laboratories
5.5.6 Other End Users
5.5.7 Y-o-Y Growth Analysis, By End User
5.5.8 Market Attractiveness Analysis, By End User
5.5.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Technology
6.1.3.5 By Application
6.1.3.6 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Technology
6.1.4.5 By Application
6.1.4.6 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Technology
6.1.5.5 By Application
6.1.5.6 By End User
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Abcm PLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bio-Rad Laboratories Inc
8.3 Biovision Inc
8.4 Cell Signaling Technology Inc
8.5 GE Healthcare
8.6 PerkinElmer Inc
8.7 Thermo Fisher Scientific
8.8 Geno Technology
8.9 Lonza Group
8.10 Merck KGaA
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
